Picture Berlin Partner Hotspot for Startups 650x80px

Document › Details

Aelis Farma S.A.. (2/15/22). "Press Release: Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Announces the Success of Its Initial Public Offering and Raises approximately €25 Million on Euronext Paris [No

	Region	Paris
	Country	France
	Organisation	Aelis Farma S.A.
	Organisation 2	Euronext Paris S.A.
	Group	Euronext (Group)
	Product	drug development
	Product 2	investment banking
	Person	Piazza, Pier Vincenzo (Aelis Farma 201912 CEO + INSERM Neurocentre Magendie Bordeaux)

Original document
accessed by [iito] on 2022-02-16

Record changed: 2022-02-17

Picture [iito] Fighting Customers 650x100px

More documents for Aelis Farma S.A.

[1] Aelis Farma. (12/13/19). "Press Release: Aelis Farma Raises €11 Million to Accelerate the Clinical Development of a Paradigm-Shifting New Class of Drugs for Treating Cannabis Addiction and Cognitive Disorders". Bordeaux....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]